tubeimoside II

from tubers of Bolbostemma paniculatum; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Retinoblastoma (Glioblastoma, Retinal) 02/01/2021 - "Tubeimoside II inhibits TGF-β1-induced metastatic progression of human retinoblastoma cells through suppressing redoxosome-dependent EGFR activation."
2.	Neoplasms (Cancer) 05/01/2001 - "However, the anti-inflammatory, anti-tumor, and anti-tumorigenic activities of tubeimoside II are stronger than those of tubeimoside I, and the acute toxicity of tubeimoside II is lower than that of tubeimoside I; the anti-inflammatory, anti-tumor, and anti-tumorigenic activities of tubeimoside III are stronger than those of tubeimoside II, and the acute toxicity of tubeimoside III is also stronger than that of tubeimoside II. C-16 hydroxyl group of tubeimoside II plays an important role in enhancing biological activity of tubeimoside II and in decreasing its toxicity. "